The emergence of next-generation sequencing (NGS) has revolutionized the study of genetics and provided valuable resources for other scientific disciplines. As NGS becomes more widely accessible, its use has extended beyond basic research and into broader clinical contexts. It is therefore increasingly important to account for the errors that arise in the sequencing process. These errors can stem from the bioinformatic analysis 1 and from experimental steps 2, 3 (which can often be mitigated through the use of replicate experiments).
The use of replicates permeates almost all scientific disciplines. However, in NGS, many researchers use sequencing read depth and bioinformatic filters to address errors in lieu of biological replication. This practice is understandable, given that replicates can substantially increase study costs. However, sequencing costs have decreased markedly 4 , and now is the time to re-evaluate the value of replication in sequencing studies.
In this Perspective article, we discuss sources of errors in sequencing and the nascent use of replication in published high-throughput sequencing efforts. In addition, we show how biological replicates can be used to reduce sequencing errors.
In particular, we demonstrate that replicates can be used to assess the specificity and the sensitivity of sequence variant-calling methods in a manner that is independent of the algorithms and the chemistry that are used to call variants, thereby guiding the appropriate selection of quality score thresholds.
Experimental errors in NGS
Technological advances and the digital nature of DNA are helping to achieve highly accurate genome sequences. However, sequencing methods are imperfect. NGS applications -such as wholegenome sequencing, targeted capture, high-throughput RNA sequencing (RNAseq) and chromatin immunoprecipitation followed by sequencing (ChIP-seq) -are prone to errors that result in miscalled bases, thus causing misalignment of short reads and mistakes in genome assembly. Reported claims of sequencing base call accuracy for leading NGS technologies greatly vary, which range from one error in one thousand nucleotides (99.9%) 5 to one error in ten million nucleotides (99.9999%) 6 . Even for methods that have the lowest reported error rates, the absolute numbers of miscalled genomic variants remain unwieldy -there might be thousands of false-positive variants in a fully sequenced human genome. Furthermore, false-positive errors are mistaken as rare and somatic variants, thereby obfuscating true variants of clinical interest. Known sources for experimental errors can be grouped by their occurrence in the sequencing workflow; that is, during sample preparation, library preparation, or sequencing and imaging (FIG. 1a; BOX 1) .
Sample preparation. Sequencing errors and biases can arise from sample degradation and contamination during sample isolation and preservation. For example, during sample preservation, formalin fixation causes degradation and nucleotide changes 7, 8 . Moreover, inadequate amounts of high-quality genomic material can increase amplification errors and decrease sequencing read depth 9 . Finally, contamination poses a challenge when non-tumour cells mask oncogenic somatic variants 10 or when exogenous DNA interferes with calls of homozygosity or heterozygosity 11 . Library preparation. Errors also arise during sequencing library preparation, which leads to uneven coverage, sequence changes and interruption of sequence tags. DNA fragmentation can produce length biases, which subsequently causes preferential amplification 12 . Library amplification is subject to unmeasured primer biases, such as primer bias in multiple displacement amplification (MDA) 13 , mispriming in PCR target enrichment 14 and incorporation of sequence errors during both clonal amplification and PCR cycling 15 . When barcodes, adaptors and other pre-defined sequence tags are added to the fragments being sequenced, disruption and inadequate tag design can result in cross-contamination of data sets, read loss and decreased read quality 2, 16 . Chimeric reads can also arise in longinsert paired-end libraries 17 and potentially confound variant calls and assembly efforts.
Sequencing and imaging. Current NGS platforms 3 have sequencing and imaging error types that are specific to the platforms 18 . For example, substitution errors can arise in platforms such as Illumina and SOLiD when incorrect bases are introduced during clonal amplification of templates. Furthermore, Illumina has shown a sequence-specific error profile 19 that possibly arises from either single-strand DNA folding or sequence-specific alterations in enzyme preference. The single-molecule, real-time (SMRT) platform of Pacific Bioscience yields long single-molecule reads that are subject to false insertions and deletions (indels) from non-fluorescing nucleotides 20, 21 . Pyrosequencing (for example, Roche 454 platforms) and semiconductor sequencing (for example, Ion Torrent) have difficulty in counting homopolymer stretches, which results in carry-forward insertion and deletion errors 22 . Experimental errors pose challenges in applications for which accuracy is crucial, such as in detection of somatic mosaicism 23, 24 and in other clinical applications. Errors are often addressed by increasing sequencing read depth but can also be mitigated by careful barcoding strategies 25 , replicates, Primary analysis e.g. base calling and quality control
Secondary analysis e.g. alignment and variant calling Tertiary analysis
Figure 1 | Sources of and tools to cope with unexpected or erroneous variants. Sequencing experiments involve many steps from sample acquisition to final data analysis, and a major challenge in the process stems from the emergence of unexpected or erroneous variants. Sequencing pipeline and sources of errors are shown; R represents a replicate. a | These variants can include legitimate somatic mosaicism and rare oncogenic variants. Additionally, many erroneous sequence variants arise during experimental steps, for example, through sample degradation, PCR amplification errors and base-calling errors. b | Several analytical tools and post-processing mechanisms are often used for separating true variation from false sequence variants. These include indicators of data quality (for example, base call and mapping quality scores) and the choice of filters that is informed by these indicators. Additional tertiary analyses can also highlight systematic biases through clustering methods and possible false-positive variants by accounting for Mendelian inheritance patterns 57 . Throughout the sequencing and post-processing pipeline, the use of replicated sequencing experiments can help to mitigate the effect of erroneous variants from the experimental steps and to inform the choice of postprocessing filters. Thus, greater accuracy of germline variant detection can be attained, and improved sensitivity can be achieved for true somatic variation.
An approach that holds promise uses the tried-and-true scientific method of replication to mitigate user errors, stochastic differences and other sources of experimental errors. Different types of replication are described below, including sequencing read depth, and technical, biological and cross-platform replication.
Sequencing read depth. The most straightforward approach to improve sensitivity and accuracy in sequence variant calls is to increase sequencing read depth 28, 29 . By increasing the number of short reads, one can improve variant calling on easily sequenced regions. Consequently, one can reduce the number of missed true variants (that is, false negatives) and sometimes the number of true non-variants that are incorrectly detected as variants (that is, false positives). However, merely increasing sequencing read depth cannot ameliorate issues that arise from the widespread batch effect phenomenon 30 and many other error types that are introduced in the experimental process. Thus, increased sequencing read depth is not necessarily an adequate proxy for biological replication and is limited in its ability to mitigate errors.
Technical replicates. The frequency of certain error types can be reduced through technical replication. We define technical replication as the repeat analysis of the exact same sample. For example, technical replicates were used with monozygotic twins, and the data showed higher intra-individual correlations than inter-individual correlations 31 . In another example 6 , many technical replicate pools were sequenced and each contained dilute DNA. Pools containing haplotypes with incongruent base calls that were suspected as amplification errors were discarded, and the sequence quality was significantly improved.
Biological replicates. We define biological replication as the preparation and the analysis of multiple biological samples under the same conditions from the same host. Biological replicates in genome sequencing can be used to assess the efficacy of various bioinformatic filters 32 . Additional benefits over technical replicates include the identification of rare somatic mosaicism and of differences in transcript abundance. Somatic mosaicism can arise from mutations that occur from mutagens and other causes 24 .
Biological replicates can indirectly help to uncover somatic mutations in complex and heterogeneous tumours when they are used to achieve the 'normal' baseline sequence in tumour-normal pairs.
Cross-platform replicates. Each sequencing platform introduces unique biases and error types. Thus, integrating sequencing data from different technologies can further mitigate errors. For example, sequencing DNA samples that were taken from both the blood and saliva on two different platformsIllumina and Complete Genomics -resulted in 88.1% concordance of single-nucleotide variants (SNVs) across replicates 33 . Validation rates for variants that were called on both platforms were higher than variants that were not. In another study, sequencing on three platforms -Illumina, Roche 454 and SOLiD -showed 64.7% concordance 5 . This disparity could result from multiple experimental error sources and from differences in downstream bioinformatic processing. Cross-platform replicates greatly reduce the number of false-positive variants, but the different biases from each sequencing platform may cause many true variants to be overlooked when cross-platform replicates are compared.
Reducing errors and replicates
As sequencing further permeates science and medicine, replicates will be invaluable to researchers and clinicians alike. Current efforts in sequencing error mitigation mainly rely on filtering strategies, including filtering for sequencing read depth, base call quality, short-read alignment quality, variant call quality, known variants, strand bias, allelic imbalance and sequence context 10, 21, 25, 27, [34] [35] [36] . All of these post-processing techniques help to reduce uncertainty in the final genotyping variant call (FIG. 1b) .
Box 1 | Experimental sources of errors in sequencing
The importance and the relative effect of each error source on downstream applications depend on many factors, such as sample acquisition, reagents, tissue type, protocol, instrumentation, experimental conditions, analytical application and the ultimate goal of the study. Sequencing errors can stem from any time point throughout the experimental workflow, including initial sequence preparation, library preparation and sequencing. Some examples are listed below.
Sample preparation
• User errors; for example, mislabelling • Degradation of DNA and/or RNA from preservation methods; for example, tissue autolysis, nucleic acid degradation and crosslinking during the preparation of formalin-fixed, paraffin-embedded (FFPE) tissues 8, 87, 88 • Alien sequence contamination; for example, those of mycoplasma and xenograft hosts 89 • Low DNA input 9
Library preparation
• User errors; for example, carry-over of DNA from one sample to the next and contamination from previous reactions 90 • PCR amplification errors 9 • Primer biases; for example, binding bias, methylation bias, biases that result from mispriming, nonspecific binding and the formation of primer dimers, hairpins and interfering pairs, and biases that are introduced by having a melting temperature that is too high or too low 91, 92 • 3ʹ-end capture bias that is introduced during poly(A) enrichment in high-throughput RNA sequencing 93 • Private mutations; for example, those introduced by repeat regions and mispriming over private variation 94 • Machine failure; for example, incorrect PCR cycling temperatures 15 • Chimeric reads 2, 17 • Barcode and/or adaptor errors; for example, adaptor contamination, lack of barcode diversity and incompatible barcodes 16, 95 Sequencing and imaging • User errors; for example, cluster crosstalk caused by overloading the flow cell 96 • Dephasing; for example, incomplete extension and addition of multiple nucleotides instead of a single nucleotide 3 • 'Dead' fluorophores, damaged nucleotides and overlapping signals 20 • Sequence context; for example, GC richness, homologous and low-complexity regions, and homopolymers 19, 97, 98 • Machine failure; for example, failure of laser, hard drive, software and fluidics • Strand biases 97 Bioinformatic filtering techniques can be optimized using technical, biological and cross-platform replicates to improve their specificity and sensitivity 32 . For example, optimal quality score thresholds for each filter may be selected using replicate genome sequences. An individual human genotype has ~3 million variants 36 ; however, variant callers can predict >20 million variants of differing quality per genome, which mainly result from mismapped short reads 37 , mosaicism and sequencing errors. Consequently, thresholds are chosen to limit the variants called in the individual's genotype. Ideally, these thresholds are chosen with experimental confirmation 38 , but this can be costly. We assert that replicates can abet bioinformatic filtering and reduce the number of variants that require validation, thereby improving the quality of the sequence that is being mapped or assembled.
To illustrate this, we use biological replicates to carry out a simple analysis for assessing the reliability of single-nucleotide substitution calls (FIG. 2) . For genotyping, the number of replicates should be chosen to attain adequate statistical power at the loci in question. However, in this case, we seek a set of probable false positives that stem from experimental errors, which requires only three replicates for a voting majority. For the replicates, we obtained sequence data from three distinct tissue samples of participant PGP1 in the Personal Genome Project 39 (see Supplementary information S1 (box)).
Loci in which one or more replicates contained a SNV were identified. Briefly, SNV loci are known as concordant when all replicate variant calls agree 40 and discordant when other replicates differ from the target replicate. Thus, concordant loci represent truepositive variants, and discordant loci signal false-positive variants. See Supplementary information S1 (box) for precise definitions of concordance and discordance, for details on choosing a target replicate and for implementation details.
Once discordant variants (potential false positives) and concordant variants (potential true positives) have been separated from each other, metrics of variant call confidence (for example, quality scores and read depth) are used to rank-order the target variants. Using the ranked sets, one can plot the accumulation rate for both concordant and discordant variants with decreasing score stringency in a representation that is similar to a receiveroperator characteristic (ROC) curve (see Supplementary information S2 (box) for methods and source code). Thus, thresholds for variant call quality scores can be chosen to maximize the proportion of all concordant variants that are seen either at or below a particular threshold relative to the proportion of all discordant variants. This analysis (FIG. 3) suggests that, although adequate sequencing read depth across the genome is essential 28, 29 , it is not the best measure of reliability of a specific variant call at a particular locus. Indeed, sequencing read depth at a particular locus is an inferior filter when it is compared with error-model-based quality scores. We found that this holds true for quality scores that are computed by software packages which process genomic 35 and expression 27 data. Even after removing regions that have abnormally high read depths (that is, regions that are enriched for misalignment errors in lowcomplexity sequences 37 ), the quality scores that are considered here still outperform read depth as a filter for sequencing errors.
In addition to comparing disparate errormodel-based quality scores, this approach can be used to evaluate the effect of varying quality score thresholds for a specific data set of interest. For example, sensitivity of a particular threshold can be evaluated by considering the false-negative rate, as estimated by the number of concordant variants that are lost as a result of applying the threshold.
Post-processing errors in NGS
Even with the use of replicates, some types of errors cannot be addressed without further technological advances and improvements in bioinformatic processing. For example, indels 41 , paralogues and other repetitive sequences 42 often confound NGS short-read alignment 43, 44 , which results in mismapped reads and, ultimately, variant call errors. Other sources of errors can arise from limitations in software and configuration during secondary analysis, including read clipping and filtering 45 , allelic bias measurement 46 and variant call confidence 
Classify variants Sequence and call variants
Replicate genomes (R1 and R2) Target genome (T)
Replicate genomes (R1 and R2) Target genome (T) calculation 47 . These cannot be addressed with replicates alone.
Erroneous variant calls also arise from incomplete reference data. This error type arises when reads are mapped to unfinished reference genomes and transcriptomes, and to drafts that contain misassembled regions 48 . These errors will steadily decrease in frequency as reference genome assemblies and annotations such as GRChr37 (REF. 49 ) and RefSeq 50 are completed and corrected with each new build release.
Finally, advances in haplotype phasing hold promise not only for reducing amplification errors 6 but also for reducing the causal variation search space. For example, only through accurate haplotype phasing can we begin to discern the difference between two dysfunctional gene copies (that is, a double mutant) and a single normal copy 51 . This difference can have important implications with regard to phenotype and to clinical applications of sequencing. Unfortunately, current mainstream NGS methods do not consistently discern between these two cases. Thus, ad hoc experimental 6, 52, 53 and computational procedures 54, 55 are required to distinguish the haplotypes of diploid cells.
Concluding remarks
In the past decades, scientific and technological advances have provided molecular-level resolution for the inner workings of life. NGS technologies are providing insights into genetic disease associations [56] [57] [58] [59] [60] [61] [62] , differences in human gut microbiota 63 , amino acid essentiality in proteins 64 , experimental evolution [65] [66] [67] , biotherapeutic development [68] [69] [70] [71] [72] , protein-DNA interactions 73 , epigenetics 74 , cancer genomics 38, 75 and clinical diagnosis 76 . Efforts to find biologically and clinically relevant variants are steadily improving, as algorithmic advances more intelligently filter the large amount of sequence data. For example, priority can be assigned to variants by considering either heritability or variant association in populations 60, 77 , correcting for gene-specific mutation rates 10 , accounting for evolutionary conservation [78] [79] [80] and providing network context through systems biology approaches [81] [82] [83] . Beyond strictly biological applications, sequencing is also becoming an analytical tool for more esoteric questions, such as recording fluctuations in ion concentrations 84 and even potentially detecting dark matter in astrophysics 85 . However, all these sequencing studies rely on the accuracy of the underlying sequencing experiments.
Here, we have identified sources of sequencing errors and presented a method for addressing the stochastic effects. Additional approaches to address other sources of errors, such as experimental bias and software limitations, are also essential. These approaches include identifying erroneous single-nucleotide polymorphisms that show Hardy-Weinberg disequilibrium 11 , masking poor-quality bases 86 , phasing and imputing variants in regions that are difficult to sequence or in uncalled regions 54 , as well as improved methods for calling of structural variants, copy number variations and indels. Together with these computational approaches, the wise use of replicate genome sequencing will have an increasingly important role in reducing the noise in data processing and in downstream analyses. The efficiency of different variant call filter metrics can be evaluated by plotting replicate-based singlenucleotide variant (SNV) concordance and discordance in a manner that is similar to a receiveroperator characteristic curve. As one goes from left to right on the plot, the quality score that has been ranked in order is reduced in stringency, and the fractions of retained concordant and discordant variants increase. Thus, this curve quantifies the proportion of reliable data (that is, concordant SNVs) that are retained and the proportion of low-confidence data (that is, discordant SNVs) that are discarded as a consequence of variable quality score cutoffs. For the genomes used in our analysis, this graph indicates that filtering variants solely on the basis of locus read depth is inferior to filtering by genomic 35 and expression 27 quality scores 35 . Furthermore, filtering by expression data quality scores is also inferior to filtering by genomic quality scores (which are obtained from Complete Genomics); nevertheless, both of these filters are better than filtering loci by read depth. The read depth curve that excludes outliers (that is, read depth that is higher than the 99.5 th -percentile) outperforms the all-inclusive read depth curve. As an example of how to understand the value of a threshold, note that choosing a threshold score of 120 as a measure for the highest quality for the genomic data will include the same fraction of total predicted errors as choosing a threshold quality score of 23,800 for the expression data. Meanwhile, when a similar threshold is chosen for read depth, the efficiency at retaining true variants is worse than that at random. See Supplementary information S2 (box) for a full description of the method. Nature Reviews | Genetics 
Glossary

Barcodes
Known DNA sequences that are appended to the ends of DNA fragments before sequencing for the purpose of pooling samples together to reduce cost.
Base call
Identification of the nitrogenous base (A, G, C or T) that is added to the short read during sequencing.
Batch effect
The statistical bias of indeterminate cause observed in samples that are processed together with the same sample preparation, the same library preparation and the same sequencing experiment.
Homopolymer
A sequence of multiple consecutive identical nucleotides.
Insertions and deletions
(Indels). Variants that are created by either the insertion or the deletion of nucleotides with respect to a matching reference.
Misalignment
The alignment of a sequencing read to an incorrect location on a reference genome. This can occur when reads align equally well to multiple genomic locations owing to indels, repeats and low-complexity regions of the genome.
Multiple displacement amplification (MDA).
A technique that is used for amplifying DNA sequences by synthesizing DNA from random hexamer primers.
Read clipping
Removal of adaptor and barcode sequences or of low-quality bases near read ends following sequencing.
Sequencing errors
Errors that are seen in the base call of short reads from next-generation sequencing technology.
Sequencing read depth
The number of reads that contributes to the variant call at a single location; also known as read depth, fold coverage and depth of coverage. It can also refer to the average read depth across the entire targeted sequence area.
Short reads
Short sequences of nucleotide bases and their respective quality scores that are obtained through next-generation sequencing from longer target sequences.
Somatic mosaicism
Genetic diversity among cells of a single organism.
Substitution errors
Errors that occur when one base is substituted for another during sequencing.
Variant call errors
An accumulation of misaligned reads or of reads with base call errors over a particular locus, which results in that locus being called a variant when it truly matches the reference, and vice versa.
